Michal Michal

20PUBLICATIONS
138CO-AUTHORS
Solid tumoursOncology and carcinogenesis not elsewhere classifiedEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Feb 24, 2026
Ossifying spindled and epithelioid tumour: Expanding the clinical and morphologic spectrum of a recently described entity.

Rayan M Sibira, Benjamin F Smith, Amy Davis

|Dec 04, 2025
FET-Rearranged Myoepithelial Tumors Are Clinically Heterogeneous and Epigenetically Distinct from PLAG1-Rearranged Adnexal and Salivary Gland Myoepithelial Tumors.

Michael Michal, Faizan Malik, Boulos Mansour

|Nov 13, 2024
Advantages of next-generation sequencing (NGS) in the molecular classifi cation of endometrial carcinomas - our experience with 270 cases.

Květoslava Michalová, Jiří Presl, Andrea Straková-Peteříková

|Oct 10, 2024
S100 and CD34 positive spindle cell tumors of the uterine cervix with EGFR mutation: a hitherto unrecognized neoplasm phenotypically and epigenetically overlapping with "NTRK-rearranged spindle cell neoplasms" of the uterus.

Michael Michal, Josef Kuruc, Veronika Hájková

|Oct 09, 2024
Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC-rearranged sarcomas: a study of 48 molecularly confirmed cases.

Rodrigo T Macedo, Vira Baranovska-Andrigo, Tamás Pancsa

|Sep 12, 2024
Update on cutaneous mesenchymal tumors in the 5th edition of WHO classification of skin tumors with an emphasis on new fusion-associated neoplasms.

Antonina V Kalmykova, Vira Baranovska-Andrigo, Michael Michal

Pageof 4

Frequent Collaborators

4 joint publications

Abbas Agaimy

4 joint publications

Kemal Kosemehmetoglu

4 joint publications

Natálie Klubíčková

3 joint publications

Steven D Billings